Ann: Notification of cessation of securities - PAA, page-66

Morning, all.

Just putting it out there - we may not receive an announcement today. As foreshadowed in the 24 May announcement:

The update to the clinicaltrials.gov register tells us that our first participant enrolled - excellent, the trial is up and running - but this is in line with previous advice. Looking at the trial protocol, which requires bloods to be taken at regular intervals over the first 24 hours, it is entirely possible that the 'treatment' part has not happened yet - not likely to be scheduled to fall over the weekend:

Just saying.

Also, for what it's worth, I've seen this level of excitement, agitation and search for the 'gotcha' moment in relation to disclosure obligations with just about every biotech I've ever been invested in once trials are imminent or running. Trials are complex, and we 'don't know what we don't know' about how they're being run, who's responsible for what, when information reaches the company from the principal investigator, whether enrolled also means dosed, etc. etc.
I think we should collectively chill out a bit - the trial is running and we'll receive updates when there's something to tell the market.

Looking forward to a good week.

Cheers

Densy